local_hospital

Bergman Clinics Nederland B.V.

Address
Gooimeer 11, 1411 DE Naarden, The Netherlands

Bergman Clinics Nederland B.V.

Bergman Clinics Nederland B.V. is a specialized clinical research facility focused on advancing evidence-based treatment strategies across multiple medical disciplines. The center demonstrates expertise in orthopedic surgery outcomes research and ophthalmology, conducting innovative studies that challenge conventional treatment protocols to optimize patient care.

  • Personalized thrombosis prophylaxis strategies in orthopedic surgery, particularly for total hip and knee arthroplasty patients
  • Venous thromboembolism (VTE) prevention and risk stratification in surgical populations
  • Pediatric ophthalmology research, including progressive myopia treatment optimization in children

The center's research portfolio includes landmark multicenter trials such as DISTINCT, which evaluates individualized thrombosis prophylaxis approaches versus standard protocols in joint replacement surgery. Additionally, their work in pediatric myopia investigates optimal dosing strategies for atropine treatment in European children, addressing both efficacy and safety outcomes. This comprehensive research approach reflects the center's commitment to precision medicine and patient-centered care across diverse therapeutic areas.

Site Overview

assignment
3
connected trials
corporate_fare
2
sponsors
science
14
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 271 other sites in The Netherlands

description
Trial volume
3
Outperforms 51% of sites
public
Therapeutic diversity
4areas
Outperforms 62% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — The Netherlands

Select a therapeutic area to compare against other sites in The Netherlands.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: The Netherlands

Market Share

Country: The Netherlands

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Bergman Clinics Nederland B.V.

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety of Corticosteroid Injections for the Treatment of Achilles Tendinopathy: A Clinical StudyErasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Phase IIIRecruitingJun 2026

IMP list

lock Showing 1 of 14 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Andexanet Alfa1Unknown2024-10-232024-10-23

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.